TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | +80.0% | 123 | -26.8% | 0.00% | – |
| Q1 2022 | $5,000 | -28.6% | 168 | +9.8% | 0.00% | – |
| Q4 2021 | $7,000 | +133.3% | 153 | +247.7% | 0.00% | – |
| Q3 2021 | $3,000 | -40.0% | 44 | -34.3% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 67 | +6.3% | 0.00% | – |
| Q1 2021 | $6,000 | -25.0% | 63 | -1.6% | 0.00% | – |
| Q4 2020 | $8,000 | +60.0% | 64 | +12.3% | 0.00% | – |
| Q3 2020 | $5,000 | +66.7% | 57 | +26.7% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 45 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 45 | +4400.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |